• 2016-05-31 Announcements

Nobelpharma signs license agreement with Danish Serendex Pharmaceuticals A/S for future commercialization of Molgradex®(inhaled GM-CSF therapy) for Pulmonary Alveolar Proteinosis in Japan

1. 
2. 一覧へ戻る（英語）
3.